Attenuation of amygdala atrophy with lamotrigine in patients receiving corticosteroid therapy

Journal of Clinical Psychopharmacology

Volumn 29, Issue 3, 2009, Pages 284-287

  Desai, Shuchi ^a   Khanani, Sadia ^a   Shad, Mujeeb U ^a   Brown, E Sherwood ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Amygdala; Atrophy; Corticosteroid; Lamotrigine; Volume

Indexed keywords

CORTICOSTEROID; LAMOTRIGINE; PLACEBO; PREDNISONE;

ADULT; AGED; AMYGDALOID NUCLEUS; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HAMILTON SCALE; HUMAN; MALE; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNSPECIFIED SIDE EFFECT; YOUNG MANIA RATING SCALE;

ADULT; AFFECT; AMYGDALA; ANALYSIS OF VARIANCE; ANTIMANIC AGENTS; FEMALE; GLUCOCORTICOIDS; GLUTAMIC ACID; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREDNISONE; PSYCHIATRIC STATUS RATING SCALES; TRIAZINES; YOUNG ADULT;

EID: 67649289849     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181a3e2a7     Document Type: Article

References (26)

1. Thompson DS, Spanier CA, Vogel VG. The relationship between tamoxifen, estrogen, and depressive symptoms. Breast J. 1999;5(6):375-382.
2. Bremner JD, McCaffery P. The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):315-331.
3. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24-31.
4. Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9(1):29-45.
5. Brown ES. Effects of glucocorticoids on mood, memory, and the hippocampus: treatment and preventive therapy. Ann N Y Acad Sci. [In press].
6. Brown ES, Suppes T, Khan DA, et al. Mood changes during prednisone bursts in outpatients with asthma. J Clin Psychopharmacol. 2002;22(1):55-61.
7. Brown ES, J Woolston D, Frol A, et al. Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. Biol Psychiatry. 2004;55(5):538-545.
8. Newcomer JW, Selke G, Melson AK, et al. Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch Gen Psychiatry. 1999;56(6):527-533.
9. Starkman MN, Gebarski SS, Berent S, et al. Hippocampal formation volume, memory dysfunction, and cortisol levels in patients with Cushing's syndrome. Biol Psychiatry. 1992;32(9):756-765.
10. Vyas A, Mitra R, Shankaranarayana Rao BS, et al. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J Neurosci. 2002;22(15):6810-6818.
11. Mitra R, Sapolsky RM. Acute corticosterone treatment is sufficient to induce anxiety and amygdaloid dendritic hypertrophy. Proc Natl Acad Sci U S A. 2008;105(14):5573-5578.
12. Merke DP, Fields JD, Keil MF, et al. Children with classic congenital adrenal hyperplasia have decreased amygdala volume: potential prenatal and postnatal hormonal effects. J Clin Endocrinol Metab. 2003;88(4):1760- 1765.
13. Merke DP, Giedd JN, Keil MF, et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab. 2005;90(5):2531-2536.
14. Brown ES, Woolston DJ, Frol AB. Amygdala volume in patients receiving chronic corticosteroid therapy. Biol Psychiatry. 2008;63(7):705-709.
15. Karl A, Schaefer M, Malta LS, et al. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev. 2006;30(7):1004-1031.
16. Hamilton JP, Siemer M, Gotlib IH. Amygdala volume in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Mol Psychiatry. 2008;13(11):993-1000.
17. Rosso IM, Killgore WD, Cintron CM, et al. Reduced amygdala volumes in first-episode bipolar disorder and correlation with cerebral white matter. Biol Psychiatry. 2007;61(6):743-749.
18. Magarinos AM, McEwen BS. Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience. 1995;69(1):89-98.
19. Magarinos AM, McEwen BS, Flugge G, et al. Chronic psychosocial stress causes apical dendritic atrophy of hippocampal CA3 pyramidal neurons in subordinate tree shrews. J Neurosci. 1996;16(10):3534-3540.
20. Brown ES, Stuard G, Liggin JD, et al. Effect of phenytoin on mood and declarative memory during prescription corticosteroid therapy. Biol Psychiatry. 2005;57(5):543-548.
21. Falk WE, Mahnke MW, Poskanzer DC. Lithium prophylaxis of corticotropin-induced psychosis. JAMA. 1979;241(10):1011-1012.
22. Brown ES, Vazquez M, Nakamura A. Randomized, placebo-controlled, crossover trial of memantine for cognitive changes with corticosteroid therapy. Biol Psychiatry. 2008;64(8):727-729.
23. Brown ES, Wolfshohl J, Shad MU, et al. Attenuation of the effects of corticosteroids on declarative memory with lamotrigine. Neuropsychopharmacology. 2008;33(10):2376-2383.
24. Calabrese JR, Shelton MD, Rapport DJ, et al. Long-term treatment of bipolar disorder with lamotrigine. J Clin Psychiatry. 2002;63(suppl 10):18-22.
25. Magnotta VA, Harris G, Andreasen NC, et al. Structural MR image processing using the BRAINS2 toolbox. Comput Med Imaging Graph. 2002;26(4):251-264.
26. Keshavan MS, Dick E, Mankowski I, et al. Decreased left amygdala and hippocampal volumes in young offspring at risk for schizophrenia. Schizophr Res. 2002;58(2-3):173-183.